<i>SETD2</i> Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer
Xinyi Zhou(University of Southern California), Gangning Liang(University of Southern California)
Cited by 19
Related Papers
Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples
|Clinical Epigenetics|2021|45
Dnmt3a2 expression during embryonic development is required for phenotypic stability
|Research Square|2025|0